Literature DB >> 18796709

Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation.

Vu Thuy Khanh Le1, Mirko Trilling1, Manuel Wilborn1, Hartmut Hengel1, Albert Zimmermann1.   

Abstract

We have investigated the role of signal transducer and activator of transcription (STAT) 2 during human cytomegalovirus (HCMV) replication and found that protein levels of STAT2 are downregulated. STAT2 downregulation was observed in HCMV clinical isolates and laboratory strains with the exception of strain Towne. The HCMV-induced loss of STAT2 protein occurred despite an increased accumulation of STAT2 mRNA; it required HCMV early gene expression. The decrease in STAT2 was sensitive to proteasome inhibition, suggesting degradation of STAT2 via the ubiquitin proteasome pathway. Notably, pUL27, the HCMV homologue of the mouse CMV pM27 protein, which mediates the selective proteolysis of STAT2, did not induce STAT2 downregulation. Moreover, preceding STAT2 degradation, alpha/beta interferon (IFN)-receptor-mediated tyrosine phosphorylation of STAT2 was inhibited in HCMV-infected cells. This effect was paralleled by impaired tyrosine activation of STAT1 and STAT3. Accordingly, IFNs affected the replication efficiency of STAT2 degrading and non-degrading HCMV strains to a similar degree. In summary, HCMV abrogates IFN receptor signalling at multiple checkpoints by independent mechanisms including UL27-independent degradation of STAT2 and a preceding blockade of STAT2 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796709     DOI: 10.1099/vir.0.2008/001669-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  45 in total

1.  ERK1 is important for Th2 differentiation and development of experimental asthma.

Authors:  Nicholas Goplen; Zunayet Karim; Lei Guo; Yonghua Zhuang; Hua Huang; Magdalena M Gorska; Erwin Gelfand; Gilles Pagés; Jacques Pouysségur; Rafeul Alam
Journal:  FASEB J       Date:  2012-01-18       Impact factor: 5.191

2.  Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir.

Authors:  Sunwen Chou
Journal:  Antimicrob Agents Chemother       Date:  2008-11-03       Impact factor: 5.191

Review 3.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

4.  Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression.

Authors:  Young-Eui Kim; Jin-Hyoung Lee; Eui Tae Kim; Hye Jin Shin; Su Yeon Gu; Hyang Sook Seol; Paul D Ling; Chan Hee Lee; Jin-Hyun Ahn
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

Review 5.  Ubiquitination-mediated regulation of interferon responses.

Authors:  Serge Y Fuchs
Journal:  Growth Factors       Date:  2012-03-07       Impact factor: 2.511

6.  Human cytomegalovirus IE1 protein disrupts interleukin-6 signaling by sequestering STAT3 in the nucleus.

Authors:  Justin M Reitsma; Hiromi Sato; Michael Nevels; Scott S Terhune; Christina Paulus
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

7.  HSV-2 inhibits type-I interferon signaling via multiple complementary and compensatory STAT2-associated mechanisms.

Authors:  Ravi-Kumar Kadeppagari; Rebecca L Sanchez; Timothy P Foster
Journal:  Virus Res       Date:  2012-05-23       Impact factor: 3.303

Review 8.  Multifaceted evasion of the interferon response by cytomegalovirus.

Authors:  Emily E Marshall; Adam P Geballe
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

Review 9.  Immunobiology of human cytomegalovirus: from bench to bedside.

Authors:  Tania Crough; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

10.  Physical requirements and functional consequences of complex formation between the cytomegalovirus IE1 protein and human STAT2.

Authors:  Steffen Krauss; Julia Kaps; Nathalie Czech; Christina Paulus; Michael Nevels
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.